Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what his Department's legal costs have been in connection with the judicial review on HIV PrEP to date.
Answered by Baroness Blackwood of North Oxford
This information is not available as the Judicial Review is still ongoing. Once proceedings have concluded, all the parties’ costs, including the Department’s, will be in the public domain.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate his Department has made of the cost of a quadrivalent vaccine programme for school-aged boys equivalent to that in place for school-aged girls; and if he will make a statement.
Answered by Jane Ellison
An estimate of the cost of extending the current programme to boys has not been made. The Joint Committee on Vaccination and Immunisation (JCVI) is currently considering the option of extending human papilloma virus vaccination to adolescent boys. Once the JCVI has reviewed the available evidence it will report its recommendations. This will inform any future policy to extend the current programme to adolescent boys.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate his Department has made of how many men who have sex with men will receive the HPV vaccination as part of the proposed pilot.
Answered by Jane Ellison
It is estimated that up to 40,000 men who have sex with men (MSM) who attend genitourinary medicine (GUM) and HIV clinics will be offered the human papillomavirus vaccination.
There has been a positive response from those invited to participate, and confidence that the pilot will include a good geographical spread of providers, including those with the highest populations of MSM, as well as in rural areas with smaller MSM populations. Public Health England is currently completing the selection of the GUM and HIV clinics that will take part in the pilot.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many pilot areas his Department plans for the HPV vaccination for men who have sex with men; where his Department plans for those pilots to take place; and if he will make a statement.
Answered by Jane Ellison
It is estimated that up to 40,000 men who have sex with men (MSM) who attend genitourinary medicine (GUM) and HIV clinics will be offered the human papillomavirus vaccination.
There has been a positive response from those invited to participate, and confidence that the pilot will include a good geographical spread of providers, including those with the highest populations of MSM, as well as in rural areas with smaller MSM populations. Public Health England is currently completing the selection of the GUM and HIV clinics that will take part in the pilot.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will give NHS England the power to commission HIV PeEP through the NHS public health functions agreement known as Section 7a; and if he will make a statement.
Answered by Jane Ellison
Work on pre-exposure prophylaxis (PrEP) is on-going and the National Institute for Health and Care Excellence (NICE) has been asked to conduct an evidence review of Truvada for PrEP in groups at high risk of HIV. The NICE evidence summary will run alongside a pilot programme that will see £2 million invested over the next two years to target those at highest risk of HIV. This evidence review and pilot programme signifies the next steps forward and will inform any subsequent decisions about commissioning.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether he has made an assessment of the cost effectiveness of HIV PeEP if only given to a very small group of high-risk individuals.
Answered by Jane Ellison
The National Institute for Health and Care Excellence is developing an evidence summary on the use of Truvada for Pre-exposure prophylaxis that is expected to be published in the autumn. The evidence summary will consider the evidence for effectiveness, safety, patient factors and resource implications including cost.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, on what date in June 2016 the HPV vaccination pilot for men who have sex with men is planned to commence; and if he will make a statement.
Answered by Jane Ellison
The first sexual health clinics involved in the pilot started offering the human papillomavirus vaccine to men who have sex with men, who are already attending the clinic for an existing appointment, on 6 June 2016.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he made of the utility of data from the clinic in Brent and Harrow which has been providing men who have sex with men with HPV vaccinations since 2012 when determining that it was necessary to conduct an HPV vaccination pilot before deciding on a national roll-out; and if he will make a statement.
Answered by Jane Ellison
Experience from the two Brent and Harrow clinics providing human papillomavirus vaccinations to men who have sex with men was shared with Public Health England and has helped to inform the development of the pilot. North West London is unlikely to be representative of England as a whole and the pilot will therefore let us consider provision of this vaccination programme in different geographical areas. It will also consider a wider age range than the service provided in these two clinics. The pilot will cover men up to 45 years of age in line with advice from the Joint Committee on Vaccination and Immunisation (JCVI). The pilot will help resolve a range of implementation issues and determine whether a national programme can be delivered through Genito-Urinary Medicine and HIV clinics at a cost effective price in line with the JCVI’s advice.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will place in the Library copies of all letters, leaflets and other material from his Department circulated to (a) stakeholders and (b) members of the public on the EU referendum; what the costs of the production and distribution of that material has been since 1 January 2016; and what he estimates the cost of any further production and distribution of such material will be between 6 May 2016 and 23 June 2016.
Answered by Jane Ellison
I refer the hon. Member to the answer given by the Minister for the Cabinet Office on 8 June 2016 to Question 38811.
Asked by: William Wragg (Independent - Hazel Grove)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he has made of the effect on demand for GP surgery places of immigration (a) in general and (b) from nationals of other EEA countries in each of the last 10 years.
Answered by Alistair Burt
Since 2013, it is been the responsibility of NHS England to determine the provision of National Health Service primary medical services. NHS England does not collect registration information in relation to immigration, nationality or European Economic Area status.